Agios Pharmaceuticals
AGIO
AGIO
197 hedge funds and large institutions have $2.47B invested in Agios Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 69
25% less capital invested
Capital invested by funds: $3.3B → $2.47B (-$824M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
197
Holding in Top 10
3
Calls
$30.3M
Puts
$23.1M
Top Buyers
| 1 | +$58.6M | |
| 2 | +$22.6M | |
| 3 | +$14.7M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$13M |
| 5 |
M&T Bank
Buffalo,
New York
|
+$10.6M |
Top Sellers
| 1 | -$34.2M | |
| 2 | -$19.3M | |
| 3 | -$10.8M | |
| 4 |
HM
HealthCor Management
New York
|
-$10.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$9.96M |